-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on Qiagen, Raises Price Target to $52

Benzinga·10/22/2026 11:29:02
Baird analyst Catherine Schulte maintains Qiagen (NYSE:QGEN) with a Outperform and raises the price target from $50 to $52.